BioCareSD February 2021 Product Catalog

Always at your service.

February 2021 PRODUCT CATALOG

1

A letter from the President

Hello!

Our team at BioCareSD is excited with anticipation at the great additions ahead for the BioCare companies and the positive changes that will impact you, our valued customer.

Over the last year, our team has been busy expanding our product portfolio, developing more service offerings, and enhancing our facilities, all of which will deliver an even greater customer service experience.

We are proud to be one of the nation’s leading specialty distributors, known for our unparalleled customer service. Our customer support team and local, field-based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We built our reputation on being a valued partner to our customers, delivering the best possible care to patients all over the country through agility and wide-reaching distribution capabilities. The foundation of all BioCare Companies is our approach to serving our customers. We will do whatever it takes to deliver life-saving therapeutics with both speed and accuracy — whenever and wherever they are needed. We are proud to support our partners in their mission to save lives.

Warm regards,

Linda Matthews President

3

What sets us apart from other specialty distributors?

BioCareSD® exists to provide fast and easy access to life-saving medications. As a trusted partner to our customers, the team at BioCareSD is relentlessly committed to expert solutions that deliver every time. Our customers are our main focus.

BioCareSD is one of the nation’s leading specialty distributors, known for our unparalleled customer service. Our customer support team and local, field- based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We feature an ever-expanding portfolio of specialty products for hematology, thrombophilia, immunology, neurology, orphan and other ultra-rare diseases. BioCareSD is an Authorized Distributor of Record for all the manufacturers we represent, so you can depend on the quality of our products. We are committed to being the industry’s most trusted healthcare partner by providing customer-oriented solutions, unmatched service levels and a unique distribution network to ensure the highest-quality patient care.

Staff onsite 24/7, 365 days a year

Guaranteed next-day and emergency same-day delivery

STAT and emergency deliveries are our specialty

Ability to reach anywhere in the country in 4 to 6 hours

We have an agile and wide-reaching distribution network

We are always at your service.

Spokane

Seattle

Milwaukee

Providence

Ramsey

Montvale

Pittsburgh

Westbury

Dayton

Denver

Kansas City

Las Vegas

Memphis

Always at your service.

Phoenix

El Paso

Dallas

Lafayette

Miami

5

FOR PATIENTS AT RISK OF INFECTION

Inside every brave patient living with primary humoral immunodeficiency (PI) is the desire to live the healthiest life possible. Introducing ASCENIV™, formerly known as RI-002, developed to help protect patients with PI. IT’sWHAT’s INSIDE THATCOUNTS ASCENIV™ is manufactured through a patented process using source plasma, which is acquired from donors screened using a microneutralization assay to detect and identify which donors possess naturally occurring neutralizing antibody titers to respiratory syncytial virus (RSV) 1 ◊ Plasma pool is derived from a minimum of 1000 unique donors and blends normal source plasma with RSV plasma In a 1-year, prospective, open-label, nonrandomized, multicenter, phase 3 study evaluating the efficacy and safety of ASCENIV™ in adult and pediatric patients with PI 2 : ◊ ZERO serious bacterial infections ◊ Secondary endpoint results: • 1.7 missed days of work/school/day care • <1 unscheduled medical visits • No hospitalizations †

AN igiv FOR PATIENTS WITH PRIMARY HUMORAL IMMUNODEFICIENCY (PI)

Indication ASCENIV (immune globulin intravenous, human) is a 10% immune globulin liquid for intravenous injection, indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age). PI includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).

Contraindications ASCENIV is contraindicated in:

Aseptic meningitis syndrome (AMS) may occur with IGIV treatments, including ASCENIV. AMS usually begins within several hours to 2 days following IGIV treatment. AMS may occur more frequently in association with high doses (2 g/kg) and/or rapid infusion of IGIV. Conduct a thorough neurological examination on patients exhibiting signs and symptoms of AMS, including cerebrospinal fluid (CSF) studies, to rule out other causes of meningitis. IGIV products, including ASCENIV, may contain blood group antibodies that can act as hemolysins and induce in vivo coating of red blood cells (RBCs) with immunoglobulin, causing a positive direct antiglobulin reaction and hemolysis. Monitor patients for clinical signs and symptoms of hemolysis, including appropriate confirmatory laboratory testing. Non-cardiogenic pulmonary edema may occur with IV administered IG. Monitor patients for pulmonary adverse reactions. If suspected, perform appropriate tests for presence of anti-neutrophil in both product and patient serum. May be managed using oxygen therapy with adequate ventilatory support. Because ASCENIV is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) and theoretically, the Creutzfeldt-Jakob disease (CJD) agent. All infections suspected by a physician to possibly have been transmitted by this product should be reported to ADMA Biologics at (1-800-458-4244) . After infusion of immunoglobulin, the transitory rise of the various passively transferred antibodies in the patient’s blood may yield positive serological testing results, with the potential for misleading interpretation. Passive transmission of antibodies to erythrocyte antigens (e.g., A, B, and D) may cause a positive direct or indirect antiglobulin (Coombs’) test. Adverse Reactions The most common adverse reactions to ASCENIV ( ≥ 5% of study subjects) were headache, sinusitis, diarrhea, gastroenteritis viral, nasopharyngitis, upper respiratory tract infection, bronchitis, and nausea. You are encouraged to report side effects of prescription drugs to ADMA Biologics @ 1-800-458-4244 or the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.

• Patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. • IgA-deficiency patients with antibodies to IgA and a history of hypersensitivity. Warnings and Precautions Severe hypersensitivity reactions may occur with IGIV products, including ASCENIV. In case of hypersensitivity, discontinue ASCENIV infusion immediately and institute appropriate treatment. Patients with known antibodies to IgA may have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions. Thrombosis may occur following treatment with immunoglobulin products and in the absence of known risk factors. Consider baseline assessment of blood viscosity in patients at risk for hyperviscosity and ensure adequate hydration before administration. For patients at risk of thrombosis, administer ASCENIV at the minimum dose and infusion rate practicable. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity. Acute renal dysfunction/failure, osmotic nephrosis, and death may occur upon use of human IGIV products. Ensure that patients are not volume depleted before administering ASCENIV. Periodic monitoring of renal function and urine output is particularly important in patients judged to be at increased risk of developing acute renal failure. Assess renal function, including measurement of blood urea nitrogen (BUN) and serum creatinine, before the initial infusion of ASCENIV and at appropriate intervals thereafter. Discontinue ASCENIV if renal function deteriorates. In at risk patients, administer ASCENIV at the minimum infusion rate practicable. Hyperproteinemia, increased serum viscosity, and hyponatremia or pseudohyponatremia may occur in patients receiving IGIV treatment, including ASCENIV. It is critical to clinically distinguish true hyponatremia from a pseudohyponatremia that is associated with or causally related to hyperproteinemia. Treatment aimed at decreasing serum free water in patients with pseudohyponatremia may lead to volume depletion, a further increase in serum viscosity, and a possible predisposition to thrombotic events.

INTRODUCING

Visit asceniv.com for more information

ADMA BIOLOGICS PATENTS ISSUED 9,107,906 - 9,714,283 - 9,815,886 IGIV=immune globulin intravenous.

Important Safety Information for ASCENIV TM (Immune Globulin Intravenous [Human] – slra 10% Liquid)

WARNING: THROMBOSIS, RENAL DYSFUNCTION AND ACUTE RENAL FAILURE Thrombosis may occur with immune globulin (IGIV) products, including ASCENIV. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors. Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of Immune Globulin Intravenous (Human) (IGIV) products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. ASCENIV does not contain sucrose. For patients at risk of thrombosis, renal dysfunction or renal failure, administer ASCENIV at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.

Study Design: A 52-week, prospective, open-label, nonrandomized, multicenter, phase 3 study that evaluated the efficacy and safety of ASCENIV (RI-002) in 59 patients with PI. IV infusions were administered at doses of 300 to 800 mg/kg every 3 or 4 weeks. Primary efficacy endpoint was the demonstration of a serious bacterial infection (SBI) rate of less than 1.0 per person-year during the 52-week treatment period. Secondary efficacy endpoints included number of missed days of work/school/activity due to infection, unscheduled visits to the physician, and days hospitalized due to infection. 2 † One patient hospitalized from study group due to post-op local wound infection from elective surgery. For additional safety information about ASCENIV, please click here to see full Prescribing Information.

References: 1. Wasserman RL, Garcia D, Greener BN, et al. Manufacturing process optimization of ADMA Biologics’ intravenous immunoglobulin products, BIVIGAM® and ASCENIV™. Immunotherapy. 2019;11(16):1423-1433. 2. ASCENIV™ Prescribing Information, ADMA Biologics, 2019.

© 2020 ADMA Biologics. All rights reserved. ASCENIV™ is a trademark of ADMA Biologics. Visit admabiologics.com

7

Always at your service.

9

AP ALBUMIN PRODUCTS Product Name Package Size NDC #

HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #

Product Category Subcategory Derivation

Product Category Subcategory Derivation

Presentation

Manufacturer

Presentation

Manufacturer

ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL

ALBUMIN/PLASMA PROTEIN FRACTION

MONOCLONAL ANTIBODY

HEMLIBRA

30 MG 50242-0920-01

VIAL

NONFACTOR

GENENTECH USA, INC.

ALBUKED

25% 50ML 76125-0792-25

VIAL

ALBUMIN

N/A

PLASMA

KEDRION BIOPHARMA

ALBUKED

25% 100ML 76125-0792-10

VIAL

ALBUMIN

N/A

PLASMA

KEDRION BIOPHARMA

MONOCLONAL ANTIBODY

HEMLIBRA

60 MG 50242-0921-01

VIAL

NONFACTOR

GENENTECH USA, INC.

ALBUKED

5% 250ML 76125-0790-25

VIAL

ALBUMIN

N/A

PLASMA

KEDRION BIOPHARMA

ALBUMIN

25% 50ML 68982-0643-01

VIAL

ALBUMIN

N/A

PLASMA

OCTAPHARMA USA

MONOCLONAL ANTIBODY

ALBUMIN

20% 100ML 68982-0633-02

VIAL

ALBUMIN

N/A

PLASMA

OCTAPHARMA USA

HEMLIBRA

105 MG 50242-0922-01

VIAL

NONFACTOR

GENENTECH USA, INC.

ALBUMIN

25% 100ML 68982-0643-02

VIAL

ALBUMIN

N/A

PLASMA

OCTAPHARMA USA

ALBUMIN

5% 250ML 68982-0623-02

VIAL

ALBUMIN

N/A

PLASMA

OCTAPHARMA USA

MONOCLONAL ANTIBODY

HEMLIBRA

150 MG 50242-0923-01

VIAL

NONFACTOR

GENENTECH USA, INC.

ALBUMIN

5% 500ML 68982-0623-03

VIAL

ALBUMIN

N/A

PLASMA

OCTAPHARMA USA

ANTITHROMBIN

ALBUMINAR

25% 50ML 00053-7680-32

VIAL

ALBUMIN

N/A

PLASMA

CSL BEHRING LLC

THROMBATE III

500 IU 13533-0602-50

VIAL

COAGULANT ANTITHROM- BIN

PLASMA

GRIFOLS USA, LLC

ALBUMINAR

25% 100ML 00053-7680-33

VIAL

ALBUMIN

N/A

PLASMA

CSL BEHRING LLC

FACTOR I

ALBURX

25% 50ML 44206-0251-05

VIAL

ALBUMIN

N/A

PLASMA

CSL BEHRING LLC

FIBRYGA

1 GRAM 68982-0347-01

VIAL

COAGULANT FACTOR I

PLASMA

OCTAPHARMA USA

ALBURX

25% 100ML 44206-0251-10

VIAL

ALBUMIN

N/A

PLASMA

CSL BEHRING LLC

RIASTAP

1000 IU 63833-0891-51

VIAL

COAGULANT FACTOR I

PLASMA

CSL BEHRING LLC

ALBURX

5% 250ML 44206-0310-25

VIAL

ALBUMIN

N/A

PLASMA

CSL BEHRING LLC

FACTOR IX

ALBURX

5% 500ML 44206-0310-50

VIAL

ALBUMIN

N/A

PLASMA

CSL BEHRING LLC

ALPHANINE

500 IU 68516-3607-02

VIAL

COAGULANT FACTOR IX PLASMA

GRIFOLS USA, LLC

ALBUTEIN

25% 20ML

68516-5216-05

VIAL

ALBUMIN

N/A

PLASMA

GRIFOLS USA, LLC

ALPHANINE

1000 IU 68516-3608-02

VIAL

COAGULANT FACTOR IX PLASMA

GRIFOLS USA, LLC

ALBUTEIN

5% 50ML

68516-5214-05

VIAL

ALBUMIN

N/A

PLASMA

GRIFOLS USA, LLC

ALPHANINE

1500 IU 68516-3609-02

VIAL

COAGULANT FACTOR IX PLASMA

GRIFOLS USA, LLC

ALBUTEIN

25% 50ML

68516-5216-01

VIAL

ALBUMIN

N/A

PLASMA

GRIFOLS USA, LLC

ALPROLIX

250 IU 71104-0966-01

VIAL

COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC

ALBUTEIN

25% 100ML 68516-5216-02

VIAL

ALBUMIN

N/A

PLASMA

GRIFOLS USA, LLC

ALPROLIX

500 IU 71104-0911-01

VIAL

COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC

ALBUTEIN

5% 250ML

68516-5214-01

VIAL

ALBUMIN

N/A

PLASMA

GRIFOLS USA, LLC

ALPROLIX

1000 IU 71104-0922-01

VIAL

COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC

ALBUTEIN

5% 500ML 68516-5214-02

VIAL

ALBUMIN

N/A

PLASMA

GRIFOLS USA, LLC

ALPROLIX

2000 IU 71104-0933-01

VIAL

COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC

FLEXBUMIN

25% 50ML 00944-0493-01

BAG

ALBUMIN

N/A

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

ALPROLIX

3000 IU 71104-0944-01

VIAL

COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC

ALPROLIX

4000 IU 71104-0977-01

VIAL

COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC

FLEXBUMIN

25% 100ML 00944-0493-02

BAG

ALBUMIN

N/A

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

BENEFIX RT

250 IU 58394-0633-03

VIAL

COAGULANT FACTOR IX RECOMBINANT

PFIZER, INC.

BENEFIX RT

500 IU 58394-0634-03

VIAL

COAGULANT FACTOR IX RECOMBINANT

PFIZER, INC.

FLEXBUMIN

5% 250ML 00944-0495-05

BAG

ALBUMIN

N/A

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

BENEFIX RT

1000 IU 58394-0635-03

VIAL

COAGULANT FACTOR IX RECOMBINANT

PFIZER, INC.

BENEFIX RT

2000 IU 58394-0636-03

VIAL

COAGULANT FACTOR IX RECOMBINANT

PFIZER, INC.

HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #

BENEFIX RT

3000 IU 58394-0637-03

VIAL

COAGULANT FACTOR IX RECOMBINANT

PFIZER, INC.

Product Category Subcategory Derivation

IDELVION

250 IU 69911-0864-02

VIAL

COAGULANT FACTOR IX RECOMBINANT

CSL BEHRING LLC

Presentation

Manufacturer

IDELVION

500 IU 69911-0865-02

VIAL

COAGULANT FACTOR IX RECOMBINANT

CSL BEHRING LLC

ANTI-INHIBITOR COAGULANT COMPLEX

IDELVION

1000 IU 69911-0866-02

VIAL

COAGULANT FACTOR IX RECOMBINANT

CSL BEHRING LLC

ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL

FEIBA

1000 IU 64193-0424-02

VIAL

INHIBITORS

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

IDELVION

2000 IU 69911-0867-02

VIAL

COAGULANT FACTOR IX RECOMBINANT

CSL BEHRING LLC

IDELVION

4000 IU 69911-0869-02

VIAL

COAGULANT FACTOR IX RECOMBINANT

CSL BEHRING LLC

MONONINE

1000 IU 00053-6233-02

VIAL

COAGULANT FACTOR IX PLASMA

CSL BEHRING LLC

FEIBA

2000 IU 64193-0425-02

VIAL

INHIBITORS

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

REBINYN

500 IU 00169-7905-01

VIAL

COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.

REBINYN

1000 IU 00169-7901-01

VIAL

COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.

FEIBA

500 IU 64193-0426-02

VIAL

INHIBITORS

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

REBINYN

2000 IU 00169-7902-01

VIAL

COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.

11

HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #

HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #

Product Category Subcategory Derivation

Product Category Subcategory Derivation

Presentation

Manufacturer

Presentation

Manufacturer

ADYNOVATE

1500 IU

00944-4627-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

RIXUBIS

250 IU 00944-3026-02

VIAL

COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

1801 - 2500 IU 00944-4625-01

ADYNOVATE

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

RIXUBIS

500 IU 00944-3028-02

VIAL

COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

ADYNOVATE

3000 IU 00944-4628-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

RIXUBIS

1000 IU 00944-3030-02

VIAL

COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

AFSTYLA

250 IU

69911-0474-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT

CSL BEHRING LLC

AFSTYLA

500 IU

69911-0475-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT

CSL BEHRING LLC

RIXUBIS

2000 IU 00944-3032-02

VIAL

COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

AFSTYLA

1000 IU

69911-0476-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT

CSL BEHRING LLC

RIXUBIS

3000 IU 00944-3034-02

VIAL

COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

AFSTYLA

2000 IU

69911-0477-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT

CSL BEHRING LLC

AFSTYLA

3000 IU

69911-0478-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT

CSL BEHRING LLC

FACTOR IX COMPLEX

AFSTYLA

2500 IU

69911-0481-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT

CSL BEHRING LLC

KCENTRA

500 IU 63833-0386-02

VIAL

COAGULANT FACTOR IX COMPLEX PLASMA COAGULANT FACTOR IX COMPLEX PLASMA COAGULANT FACTOR IX COMPLEX PLASMA COAGULANT FACTOR IX COMPLEX PLASMA

CSL BEHRING LLC

ELOCTATE

250 IU

71104-0801-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

KCENTRA

1000 IU 63833-0387-02

VIAL

CSL BEHRING LLC

ELOCTATE

500 IU

71104-0802-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

PROFILNINE

500 IU 68516-3207-01

VIAL

GRIFOLS USA, LLC

ELOCTATE

700 IU

71104-0803-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

ELOCTATE

1000 IU

71104-0804-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

PROFILNINE

1000 IU 68516-3208-02

VIAL

GRIFOLS USA, LLC

ELOCTATE

1500 IU

71104-0805-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

FACTOR VIIA

ELOCTATE

2000 IU

71104-0806-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

NOVOSEVEN RT

1 MG 00169-7201-01

VIAL

INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.

ELOCTATE

3000 IU

71104-0807-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

NOVOSEVEN RT

2 MG 00169-7202-01

VIAL

INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.

ELOCTATE

4000 IU

71104-0808-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

NOVOSEVEN RT

5 MG 00169-7205-01

VIAL

INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.

ELOCTATE

5000 IU

71104-0809-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

NOVOSEVEN RT

8 MG 00169-7208-01

VIAL

INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.

ELOCTATE

6000 IU

71104-0810-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC

SEVENFACT

1MG

71127-1000-01

VIAL

INHIBITORS FACTOR VIIA RECOMBINANT

HEMA BIOLOGICS

ESPEROCT

500 IU

00169-8500-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

SEVENFACT

5MG

71127-5000-01

VIAL

INHIBITORS FACTOR VIIA RECOMBINANT

HEMA BIOLOGICS

FACTOR VIII

ESPEROCT

1000 IU

00169-8100-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

1801 IU - 2400 IU 00944-3045-10 2401 IU - 3600 IU 00944-3046-10 3601 IU - 4800 IU 00944-3047-10

ADVATE

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

ESPEROCT

1500 IU

00169-8150-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

ESPEROCT

2000 IU 00169-8200-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

ADVATE

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

ESPEROCT

3000 IU

00169-8300-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

ADVATE

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

220 IU – 400 IU 401 IU – 800 IU 801 IU – 1700 IU

HEMOFIL

00944-3940-02

VIAL

COAGULANT FACTOR VIII

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

200 IU - 400 IU 401 IU - 800 IU 801 IU - 1200 IU 1201 IU - 1800 IU 401 IU - 800 IU

ADVATE

00944-3051-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

HEMOFIL

00944-3942-02

VIAL

COAGULANT FACTOR VIII

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

ADVATE

00944-3052-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

HEMOFIL

00944-3944-02

VIAL

COAGULANT FACTOR VIII

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

ADVATE

00944-3053-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

1501 IU – 2000 IU 00944-3946-02

HEMOFIL

VIAL

COAGULANT FACTOR VIII

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

ADVATE

00944-3054-02

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

JIVI

500 IU

00026-3942-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

ADYNOVATE

00944-4623-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

JIVI

1000 IU

00026-3944-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

ADYNOVATE

750 IU

00944-4626-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

JIVI

2000 IU 00026-3946-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

801 IU - 1250 IU

ADYNOVATE

00944-4624-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

JIVI

3000 IU 00026-3948-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

13

HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #

HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #

Product Category Subcategory Derivation

Product Category Subcategory Derivation

Presentation

Manufacturer

Presentation

Manufacturer

KOATE

250 IU

76125-0256-20

VIAL

COAGULANT FACTOR VIII

PLASMA

KEDRION BIOPHARMA

XYNTHA SOLOFUSE

250 IU

58394-0022-03

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

KOATE

500 IU

76125-0668-30

VIAL

COAGULANT FACTOR VIII

PLASMA

KEDRION BIOPHARMA

XYNTHA SOLOFUSE

500 IU

58394-0023-03

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

KOATE

1000 IU

76125-0676-50

VIAL

COAGULANT FACTOR VIII

PLASMA

KEDRION BIOPHARMA

XYNTHA SOLOFUSE

1000 IU

58394-0024-03

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

KOGENATE

250 IU

00026-3782-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

XYNTHA SOLOFUSE

2000 IU 58394-0025-03

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

KOGENATE

500 IU

00026-3783-35

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

XYNTHA SOLOFUSE

3000 IU 58394-0016-03

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

KOGENATE

1000 IU

00026-3785-55

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

FACTOR VIII WITH VON WILLEBRAND FACTOR

KOGENATE

2000 IU 00026-3786-65

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

KOGENATE

3000 IU 00026-3787-75

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

ALPHANATE

250 IU

68516-4611-01

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

GRIFOLS USA, LLC

KOVALTRY

250 IU

00026-3821-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

ALPHANATE

500 IU

68516-4612-01

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

GRIFOLS USA, LLC

KOVALTRY

500 IU

00026-3822-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

KOVALTRY

1000 IU

00026-3824-25

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

ALPHANATE

1000 IU

68516-4613-02

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

GRIFOLS USA, LLC

KOVALTRY

2000 IU 00026-3826-50

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

KOVALTRY

3000 IU 00026-3828-50

VIAL

COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION

ALPHANATE

1500 IU

68516-4614-02

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

GRIFOLS USA, LLC

NOVOEIGHT

250 IU

00169-7825-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

ALPHANATE

2000 IU

68516-4615-02

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

GRIFOLS USA, LLC

NOVOEIGHT

500 IU

00169-7850-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

NOVOEIGHT

1000 IU

00169-7810-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

HUMATE-P

600 RCOF

63833-0615-02

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

CSL BEHRING LLC

NOVOEIGHT

1500 IU

00169-7815-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

NOVOEIGHT

2000 IU

00169-7820-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

HUMATE-P

1200 RCOF 63833-0616-02

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

CSL BEHRING LLC

NOVOEIGHT

3000 IU

00169-7830-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.

NUWIQ

250 IU

68982-0139-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

OCTAPHARMA USA

HUMATE-P

2400 RCOF 63833-0617-02

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

CSL BEHRING LLC

NUWIQ

500 IU

68982-0141-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

OCTAPHARMA USA

WILATE

500 RCOF

68982-0182-01

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

OCTAPHARMA USA

NUWIQ

1000 IU

68982-0143-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

OCTAPHARMA USA

NUWIQ

2000 IU

68982-0145-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

OCTAPHARMA USA

WILATE

1000 RCOF 68982-0182-02

VIAL

COAGULANT FACTOR VIII WITH VWF

PLASMA

OCTAPHARMA USA

NUWIQ

2500 IU

68982-0147-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

OCTAPHARMA USA

FACTOR X

NUWIQ

3000 IU

68982-0149-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

OCTAPHARMA USA

BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES

NUWIQ

4000 IU

68982-0151-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

OCTAPHARMA USA

COAGADEX

250 IU

64208-7752-01

VIAL

COAGULANT FACTOR X PLASMA

1-PACK 500 AU

OBIZUR

00944-5001-01

VIAL

INHIBITORS FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

COAGADEX

500 IU

64208-7753-01

VIAL

COAGULANT FACTOR X PLASMA

FACTOR XA

220 IU – 400 IU

RECOMBINATE

00944-2841-10

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

200 MG VIAL

CARTON: 4 VIALS/CTN COAGULANT FACTOR XA RECOMBINANT

PORTOLA PHARMACEUTICALS, INC.

ANDEXXA

69853-0102-01

401 IU – 800 IU

RECOMBINATE

00944-2842-10

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

FACTOR XIII

CORIFACT

1000 IU

63833-0518-02

VIAL

COAGULANT FACTOR XIII

PLASMA

CSL BEHRING LLC

801 IU – 1240 IU

RECOMBINATE

00944-2843-10

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

VON WILLEBRAND FACTOR

VON WIL- LEBRAND FACTOR VON WIL- LEBRAND FACTOR VON WIL- LEBRAND FACTOR VON WIL- LEBRAND FACTOR

1241 IU -1800 IU 00944-2844-10

RECOMBINATE

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

CABLIVI

11 MG

58468-0225-01

VIAL

COAGULANT

RECOMBINANT

SANOFI GENZYME

1801 IU– 2400 IU 00944-2845-10

RECOMBINATE

VIAL

COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

STIMATE

1.5MG

00053-6871-00

SPRAY COAGULANT

RECOMBINANT

CSL BEHRING LLC

XYNTHA

250 IU

58394-0012-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

450 – 850 IU

XYNTHA

500 IU

58394-0013-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

VONVENDI

00944-7551-02

VIAL

COAGULANT

RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

XYNTHA

1000 IU

58394-0014-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

900 – 1700 IU

VONVENDI

00944-7553-02

VIAL

COAGULANT

RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.

XYNTHA

2000 IU

58394-0015-01

VIAL

COAGULANT FACTOR VIII RECOMBINANT

PFIZER, INC.

15

HG IMMUNOOGY PRODUCTS - HYPERIMMUNE GLOBULIN Product Name Package Size NDC # Presentation Product Category Subcategory Derivation

IG IMMUNOOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC #

Manufacturer

Presentation Product Category Subcategory Derivation

Manufacturer

CYTOMEGALOVIRUS IMMUNE GLOBULIN

INTRAVENOUS IMMUNE GLOBULIN

CYTOGAM

2.5 GRAMS 44206-0532-11

VIAL

HYPER IMMUNE

IG

PLASMA SAOL THERAPEUTICS, INC.

ASCENIV

5 GRAM 69800-0250-01

VIAL

IVIG

IG

PLASMA

ADMA BIOLOGICS

ITRAMUSCULAR IMMUNE GLOBULIN

BIGAM

5 GRAM 69800-6502-01

VIAL

IVIG

IG

PLASMA

ADMA BIOLOGICS

GAMASTAN

2 ML

13533-0335-04

VIAL

HYPER IMMUNE

IG

PLASMA

GRIFOLS USA, LLC

GAMMAGARD - LIQUID

1 GRAM 00944-2700-02

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

GAMASTAN

10 ML

13533-0335-12

VIAL

HYPER IMMUNE

IG

PLASMA

GRIFOLS USA, LLC

GAMMAGARD - LIQUID 2.5 GRAM 00944-2700-03

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

HEPATITIS B IMMUNE GLOBULIN

GAMMAGARD - LIQUID

5 GRAM 00944-2700-04

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

HEPAGAM

1 ML

70257-0052-51

VIAL

HYPER IMMUNE

IG

PLASMA SAOL THERAPEUTICS, INC.

HEPAGAM

5 ML

70257-0051-51

VIAL

HYPER IMMUNE

IG

PLASMA SAOL THERAPEUTICS, INC.

GAMMAGARD - LIQUID

10 GRAM 00944-2700-05

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

NABI-HB

5ML

69800-4203-01

VIAL

HYPER IMMUNE

IG

PLASMA

ADMA BIOLOGICS

GAMMAGARD - LIQUID 20 GRAM 00944-2700-06

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

RABIES IMMUNE GLOBULIN

GAMMAGARD - LIQUID 30 GRAM 00944-2700-07

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

HYPERRAB

2 ML

13533-0618-02

VIAL

HYPER IMMUNE

IG

PLASMA

GRIFOLS USA, LLC

GAMMAGARD - S/D

5 GRAM 00944-2656-03

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

HYPERRAB

10 ML

13533-0618-10

VIAL

HYPER IMMUNE

IG

PLASMA

GRIFOLS USA, LLC

GAMMAGARD - S/D

10 GRAM 00944-2658-04

VIAL

IVIG

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

KEDRAB

2 ML

76125-0150-02

VIAL

HYPER IMMUNE

IG

PLASMA

KEDRION BIOPHARMA

GAMMAKED

1 GRAM 76125-0900-01

VIAL

IVIG

IG

PLASMA

KEDRION BIOPHARMA

KEDRAB

10 ML

76125-0150-10

VIAL

HYPER IMMUNE

IG

PLASMA

KEDRION BIOPHARMA

TETANUS IMMUNE GLOBULIN

GAMMAKED

5 GRAM 76125-0900-50

VIAL

IVIG

IG

PLASMA

KEDRION BIOPHARMA

HYPERTET

250 IU 13533-0634-02

SYRINGE HYPER IMMUNE

IG

PLASMA

GRIFOLS USA, LLC

GAMMAKED

10 GRAM 76125-0900-10

VIAL

IVIG

IG

PLASMA

KEDRION BIOPHARMA

VARICELLA ZOSTER IMMUNE GLOBULIN

GAMMAKED

20 GRAM 76125-0900-20

VIAL

IVIG

IG

PLASMA

KEDRION BIOPHARMA

BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES

VARIZIG

125 IU 70257-0126-51

VIAL

HYPER IMMUNE

IG

PLASMA SAOL THERAPEUTICS, INC.

GAMMAPLEX 5%

5% 5 GRAM 64208-8234-06

VIAL

IVIG

IG

PLASMA

RHO(D) IMMUNE GLOBULIN

GAMMAPLEX 5%

5% 10 GRAM 64208-8234-07

VIAL

IVIG

IG

PLASMA

MICRHOGAM

1 PACK 00562-7806-01

SYRINGE

RH IMMUNE

N/A

PLASMA

KEDRION BIOPHARMA

GAMMAPLEX 5%

5% 20 GRAM 64208-8234-08

VIAL

IVIG

IG

PLASMA

RHOGAM

1 PACK 00562-7805-01

SYRINGE

RH IMMUNE

N/A

PLASMA

KEDRION BIOPHARMA

GAMMAPLEX 10%

10% 5 GRAM 64208-8235-05

VIAL

IVIG

IG

PLASMA

GAMMAPLEX 10%

10% 10 GRAM 64208-8235-06

VIAL

IVIG

IG

PLASMA

HYPERRHO

1500 IU 13533-0631-02

VIAL

RH IMMUNE

IG

PLASMA

GRIFOLS USA, LLC

GAMMAPLEX 10%

10% 20 GRAM 64208-8235-07

VIAL

IVIG

IG

PLASMA

RHOPHYLAC

300 MCG 44206-0300-10 PACK, 10 SYRINGES RH IMMUNE

IG

PLASMA

CSL BEHRING LLC

GAMUNEX

1 GRAM 13533-0800-12

VIAL

IVIG

IG

PLASMA

GRIFOLS USA, LLC

300 UG (1500 IU)

GAMUNEX

2.5 GRAM 13533-0800-15

VIAL

IVIG

IG

PLASMA

GRIFOLS USA, LLC

WINRHO

70257-0330-51

VIAL

RH IMMUNE

IG

PLASMA SAOL THERAPEUTICS, INC.

GAMUNEX

5 GRAM 13533-0800-20

VIAL

IVIG

IG

PLASMA

GRIFOLS USA, LLC

500 UG (2500 IU)

WINRHO

70504-3500-02

VIAL

RH IMMUNE

IG

PLASMA SAOL THERAPEUTICS, INC.

GAMUNEX

10 GRAM 13533-0800-71

VIAL

IVIG

IG

PLASMA

GRIFOLS USA, LLC

GAMUNEX

20 GRAM 13533-0800-24

VIAL

IVIG

IG

PLASMA

GRIFOLS USA, LLC

1000 UG (5000 IU)

WINRHO

70257-0310-51

VIAL

RH IMMUNE

IG

PLASMA SAOL THERAPEUTICS, INC.

GAMUNEX

40 GRAM 13533-0800-40

VIAL

IVIG

IG

PLASMA

GRIFOLS USA, LLC

17

IG IMMUNOOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC #

IG IMMUNOOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC #

Presentation Product Category Subcategory Derivation

Manufacturer

Presentation Product Category Subcategory Derivation

Manufacturer

OCTAGAM 5%

1% 5 GRAM 68982-0840-01

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HIZENTRA PFS

1 GRAM 44206-0456-21

VIAL

SUBQ

IG

PLASMA

CSL BEHRING LLC

OCTAGAM 5%

2.5% 5 GRAM 68982-0840-02

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HIZENTRA PFS

2 GRAM 44206-0457-22

VIAL

SUBQ

IG

PLASMA

CSL BEHRING LLC

OCTAGAM 5%

5% 5 GRAM 68982-0840-03

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HIZENTRA PFS

4 GRAM 44206-0458-24

VIAL

SUBQ

IG

PLASMA

CSL BEHRING LLC

OCTAGAM 5%

5% 10 GRAM 68982-0840-04

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HYQVIA

2.5 GRAM 00944-2510-02

VIAL

SUBQ

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

OCTAGAM 10%

10% 2 GRAM 68982-0850-01

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HYQVIA

5 GRAM 00944-2511-02

VIAL

SUBQ

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

OCTAGAM 10%

10% 5 GRAM 68982-0850-02

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

OCTAGAM 10%

10% 10 GRAM 68982-0850-03

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HYQVIA

10 GRAM 00944-2512-02

VIAL

SUBQ

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

OCTAGAM 10%

10% 20 GRAM 68982-0850-04

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

OCTAGAM 10%

10% 30 GRAM 68982-0850-05

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HYQVIA

20 GRAM 00944-2513-02

VIAL

SUBQ

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

PANZYGA

2.5 GRAM 68982-0820-02

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

HYQVIA

30 GRAM 00944-2514-02

VIAL

SUBQ

IG

PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

PANZYGA

5 GRAM 68982-0820-03

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

XEMBIFY

1 GRAM 13533-0810-05

VIAL

SUBQ

IG

PLASMA

GRIFOLS USA, LLC

PANZYGA

10 GRAM 68982-0820-04

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

XEMBIFY

2 GRAM 13533-0810-10

VIAL

SUBQ

IG

PLASMA

GRIFOLS USA, LLC

PANZYGA

20 GRAM 68982-0820-05

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

XEMBIFY

4 GRAM 13533-0810-20

VIAL

SUBQ

IG

PLASMA

GRIFOLS USA, LLC

PANZYGA

30 GRAM 68982-0820-06

VIAL

IVIG

IG

PLASMA

OCTAPHARMA USA

XEMBIFY

10 GRAM 13533-0810-50

VIAL

SUBQ

IG

PLASMA

GRIFOLS USA, LLC

PRIGEN

5 GRAM 44206-0436-05

VIAL

IVIG

IG

PLASMA

CSL BEHRING LLC

PRIGEN

10 GRAM 44206-0437-10

VIAL

IVIG

IG

PLASMA

CSL BEHRING LLC

PRIGEN

20 GRAM 44206-0438-20

VIAL

IVIG

IG

PLASMA

CSL BEHRING LLC

NP NEUROLOGY PRODUCTS Product Name Package Size NDC #

PRIGEN

40 GRAM 44206-0439-40

VIAL

IVIG

IG

PLASMA

CSL BEHRING LLC

Product Category Subcategory Derivation

Presentation

Manufacturer

SUBCUTANEOUS IMMUNE GLOBULIN

AMYOTROPHIC LATERAL SCLEROSIS (ALS)

CUTAQUIG

1 GRAM 00069-1061-02

VIAL

SUBQ

IG

PLASMA

PFIZER, INC.

CUTAQUIG

2 GRAM 00069-1476-02

VIAL

SUBQ

IG

PLASMA

PFIZER, INC.

RADICAVA

30MG/100 ML 70510-2171-02

CARTON RADICAVA SPECIALTY RECOMBINANT MITSUBISHI TANABE PHARMA AMERICA, INC.

CUTAQUIG

4 GRAM 00069-1509-02

VIAL

SUBQ

IG

PLASMA

PFIZER, INC.

CUTAQUIG

8 GRAM 00069-1965-02

VIAL

SUBQ

IG

PLASMA

PFIZER, INC.

CUTAQUIG

1 GRAM 68982-0810-01

VIAL

SUBQ

IG

PLASMA

OCTAPHARMA USA

CUTAQUIG

2 GRAM 68982-0810-03

VIAL

SUBQ

IG

PLASMA

OCTAPHARMA USA

CUTAQUIG

4 GRAM 68982-0810-05

VIAL

SUBQ

IG

PLASMA

OCTAPHARMA USA

CUTAQUIG

8 GRAM 68982-0810-06

VIAL

SUBQ

IG

PLASMA

OCTAPHARMA USA

HIZENTRA

1 GRAM 44206-0451-01

VIAL

SUBQ

IG

PLASMA

CSL BEHRING LLC

HIZENTRA

2 GRAM 44206-0452-02

VIAL

SUBQ

IG

PLASMA

CSL BEHRING LLC

HIZENTRA

4 GRAM 44206-0454-04

VIAL

SUBQ

IG

PLASMA

CSL BEHRING LLC

HIZENTRA

10 GRAM 44206-0455-10

VIAL

SUBQ

IG

PLASMA

CSL BEHRING LLC

19

SP SPECIALTY PRODUCTS Product Name Package Size NDC #

Product Category Subcategory Derivation

Presentation

Manufacturer

Interested in having your ad featured in our catalog? Contact marketing@biocare.com to learn more!

SNAKE BITE

1 CARTON = 1 VIAL

ANAVIP

66621-0790-02

VIAL

SPECIALTY SPECIALTY RECOMBINANT MCKESSON SPECIALTY CARE DISTRIBUTION

CROFAB

2 ML

50633-0110-12 CARTON, 2 VIALS PER SPECIALTY SPECIALTY

BTG INTERNATIONAL, INC.

HEREDITARY ANGIOEDEMA (HAE)

BERINERT

500 UNITS 63833-0825-02

VIAL

SPECIALTY SPECIALTY PLASMA

CSL BEHRING LLC

PROTEIN C DEFICIENCY

CEPROTIN

500 IU 00944-4177-05

VIAL

SPECIALTY SPECIALTY PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

CEPROTIN

1000 IU 00944-4179-10

VIAL

SPECIALTY SPECIALTY PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.

Download Media Kit

VACCINE

PACK, 10 VIALS PER

ENGERIX

1 ML

58160-0821-11

VACCINE

SPECIALTY RECOMBINANT

HENRY SCHEIN, INC.

ULCERATIVE COLITIS & CROHN'S DISEASE

TAKEDA PHARMACEUTICALS AMERICAS, INC.

ENTYVIO

300MG 20ML 64764-0300-20

VIAL

SPECIALTY SPECIALTY MONOCLONAL ANTIBODY

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

SOLIRIS

300MG/ML 25682-0001-01

VIAL

SPECIALTY SPECIALTY

ALEXION

BIOSURGICAL

BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION

FLOSEAL

5ML

85412-5237-38

EACH FIBRIN SEALANT SPECIALTY PLASMA

SD VALUPAK 2 ML

TISSEEL

00338-4210-02

EACH FIBRIN SEALANT SPECIALTY PLASMA

TISSEEL

2 ML

00338-4301-02

EACH FIBRIN SEALANT SPECIALTY PLASMA

TISSEEL

4 ML

00338-4302-04

EACH FIBRIN SEALANT SPECIALTY PLASMA

TISSEEL

10 ML

00338-4303-10

EACH FIBRIN SEALANT SPECIALTY PLASMA

TISSEEL

FROZEN 2 ML 00944-8402-02

EACH FIBRIN SEALANT SPECIALTY PLASMA

TISSEEL

FROZEN 4 ML 00338-8402-04

EACH FIBRIN SEALANT SPECIALTY PLASMA

TISSEEL

FROZEN 10 ML 00338-8402-10

EACH FIBRIN SEALANT SPECIALTY PLASMA

21

Page 1 Page 2-3 Page 4-5 Page 6-7 Page 8-9 Page 10-11 Page 12-13 Page 14-15 Page 16-17 Page 18-19 Page 20-21 Page 22-23 Page 24

www.biocaresd.com

Powered by